BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 114566)

  • 1. Bromocriptine induced pregnancy in two cases of euprolactinemic hypothalamic amenorrhea.
    Nencioni T; Miragoli A; Dorato F; Polvani F
    J Endocrinol Invest; 1978 Jan; 1(1):65-7. PubMed ID: 114566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of ovulation in patients with normoprolactinemic amenorrhea by combined therapy with bromocriptine and clomiphene.
    Koike K; Aono T; Miyake A; Tsutsumi H; Matsumoto K; Kurachi K
    Fertil Steril; 1981 Feb; 35(2):138-41. PubMed ID: 6781935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis.
    Le Roith D; Potashnik G; Glick SM
    Int J Fertil; 1979; 24(2):145-7. PubMed ID: 40911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia in cases of infertility and amenorrhea.
    Furuhjelm M; Rydner T; Carlström K
    Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with bromocriptine and clomiphene citrate for patients with normoprolactinemic amenorrhea.
    Kubota T; Kamada S; Aso T
    Int J Fertil; 1992; 37(5):277-82. PubMed ID: 1358838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of bromocriptine on FSH and LH secretion in women with euprolactinemic anovulation (author's transl)].
    Mori H; Aisaka K; Kigawa T; Minakuchi H; Sakamoto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1741-8. PubMed ID: 6796631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
    Seppälä M; Unnérus HA; Hirvonen E; Ranta T
    J Clin Endocrinol Metab; 1976 Aug; 43(2):474-7. PubMed ID: 950375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between pituitary reserve and efficacy of bromocriptine in women with euprolactinemic ovulatory dysfunction.
    Lin KC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 May; 10(5):222-8. PubMed ID: 8040924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E; Ranta T; Seppäla M
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRL action on E2 ovarian secretion.
    Polatti F; Nava C; Brambilla A; Zara C
    Clin Exp Obstet Gynecol; 1982; 9(3):160-4. PubMed ID: 6819897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
    Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
    Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal changes induced by bromocriptine (CB-154) at the early stage of treatment.
    Strauch G; Valcke JC; Mahoudeau JA; Bricaire H
    J Clin Endocrinol Metab; 1977 Mar; 44(3):588-90. PubMed ID: 576425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases].
    Kato K; Watanabe R; Ito E; Sakamoto T; Morishima M; Hoshino K; Tanaka M; Tadokoro N
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin-releasing hormone and gonadotropin-releasing hormone test to predict effectiveness of bromocriptine therapy in infertile women.
    Lin KC; Okamura H; Koshida M; Mori T
    Fertil Steril; 1986 Nov; 46(5):846-51. PubMed ID: 3096783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
    Rudolf K; Smid I; Kunkel S; Bazsa-Kassai Z
    Zentralbl Gynakol; 1985; 107(14):894-8. PubMed ID: 3929499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.